Athira Pharma

Athira Pharma company information, Employees & Contact Information

Updated June 2026

Quick answer

Athira Pharma is a Biotechnology company and founded in 2011. It has approximately 41 employees on record. Contact data was last refreshed in June 2026. Find Athira Pharma's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Athira Pharma email format Athira Pharma management contacts

Related company profiles:

At Athira, we aim to restore neuronal health for those suffering from neurological diseases, including Alzheimer’s, Parkinson’s disease dementia, and dementia with Lewy bodies. We are a motivated, impassioned team committed to making a positive impact on human health.

Company Details

Employees
41
Founded
2011
Address
18706 N Creek Pkwy,
Phone
(206) 221-8112
Email
in****@****ira.com
Industry
Biotechnology
Website
athira.com
Keywords
Drug discovery and development, Age-related neurodegenerative diseases, Alzheimer's Disease, Parkinson's Disease.
HQ
Bothell, Washington
Competitors
Arsenal Biosciences, Inc., Lykos Therapeutics, Vaxcyte, BioMarin Pharmaceutical Inc., IN8bio, Genespire, Hoth Therapeutics, Inc, Emergent BioSolutions, Travere Therapeutics, OrsoBio.
Looking for a particular Athira Pharma employee's phone or email?

Athira Pharma Questions

News

Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025 - Yahoo Finance

Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025 Yahoo Finance

Athira Pharma Announces Reverse Stock Split - GlobeNewswire

Athira Pharma Announces Reverse Stock Split GlobeNewswire

10-for-1 Reverse Split: Athira Pharma Restructures Shares to Maintain Nasdaq Listing, Boost Appeal - Stock Titan

10-for-1 Reverse Split: Athira Pharma Restructures Shares to Maintain Nasdaq Listing, Boost Appeal Stock Titan

Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update Yahoo Finance

Athira Pharma to Participate in Upcoming June Conferences - Investing News Network

Athira Pharma to Participate in Upcoming June Conferences Investing News Network

Athira Pharma Presents Promising Preclinical Data on ATH-1105 for Neuroprotection in ALS at International Symposium - Quiver Quantitative

Athira Pharma Presents Promising Preclinical Data on ATH-1105 for Neuroprotection in ALS at International Symposium Quiver Quantitative

ACT-AD: Fosgonimeton in mild-to-moderate Alzheimer’s disease – first results of a randomized, placebo-controlled, 26-week Phase 2 proof-of-concept trial - Wiley

ACT-AD: Fosgonimeton in mild-to-moderate Alzheimer’s disease – first results of a randomized, placebo-controlled, 26-week Phase 2 proof-of-concept trial Wiley

Alzheimer’s Treatment Leverages Natural Repair Mechanism - Genetic Engineering and Biotechnology News

Alzheimer’s Treatment Leverages Natural Repair Mechanism Genetic Engineering and Biotechnology News

Athira Pharma Appoints Rachel Lenington as Chief Technology Officer - citybiz

Athira Pharma Appoints Rachel Lenington as Chief Technology Officer citybiz

M3 Biotechnology Announces Name Change to Athira Pharma, Inc. - PR Newswire

M3 Biotechnology Announces Name Change to Athira Pharma, Inc. PR Newswire

Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action - FinancialContent

Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action FinancialContent

ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS - Frontiers

ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS Frontiers

Athira Pharma to Present Data from First-in-Human Phase 1 - GlobeNewswire

Athira Pharma to Present Data from First-in-Human Phase 1 GlobeNewswire

Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer - PR Newswire

Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer PR Newswire

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer - Yahoo Finance

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer Yahoo Finance

ATHA Stock Price and Chart — NASDAQ:ATHA - TradingView

ATHA Stock Price and Chart — NASDAQ:ATHA TradingView

Companies like Athira Pharma

BioMarin Pharmaceutical Inc. logo - Similar company to Athira Pharma

Biomarin Pharmaceuti...

3.12K
Lykos Therapeutics logo - Similar company to Athira Pharma

Lykos Therapeutics

90
Vaxcyte logo - Similar company to Athira Pharma

Vaxcyte

492
OrsoBio logo - Similar company to Athira Pharma

Orsobio

19
Arsenal Biosciences, Inc. logo - Similar company to Athira Pharma

Arsenal Biosciences,...

298
Hoth Therapeutics, Inc logo - Similar company to Athira Pharma

Hoth Therapeutics, Inc

8
IN8bio logo - Similar company to Athira Pharma

In8Bio

28
Genespire logo - Similar company to Athira Pharma

Genespire

14
Emergent BioSolutions logo - Similar company to Athira Pharma

Emergent Biosolutions

1.43K
Travere Therapeutics logo - Similar company to Athira Pharma

Travere Therapeutics

438

Top Athira Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant